136 related articles for article (PubMed ID: 19735996)
1. When selecting an HLA mismatched stem cell donor consider donor immune status.
van Rood JJ; Oudshoorn M
Curr Opin Immunol; 2009 Oct; 21(5):538-43. PubMed ID: 19735996
[TBL] [Abstract][Full Text] [Related]
2. Searching for alternative hematopoietic stem cell donors for pediatric patients.
Rocha V; Locatelli F
Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
[TBL] [Abstract][Full Text] [Related]
3. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
[TBL] [Abstract][Full Text] [Related]
4. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
[TBL] [Abstract][Full Text] [Related]
5. The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation.
Witt CS
Curr Opin Immunol; 2009 Oct; 21(5):531-7. PubMed ID: 19765964
[TBL] [Abstract][Full Text] [Related]
6. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation.
Teshima T; Matsuoka K; Ichinohe T
Arch Immunol Ther Exp (Warsz); 2006; 54(3):165-72. PubMed ID: 16652218
[TBL] [Abstract][Full Text] [Related]
7. Role of HLA in hematopoietic SCT.
Nowak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell donor selection: the Europdonor experience.
Oudshoorn M; van Walraven SM; Bakker JN; Lie JL; V D Zanden HG; Heemskerk MB; Claas FH
Hum Immunol; 2006 Jun; 67(6):405-12. PubMed ID: 16728261
[TBL] [Abstract][Full Text] [Related]
9. Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes.
Schmidt AH; Stahr A; Baier D; Schumacher S; Ehninger G; Rutt C
Bone Marrow Transplant; 2007 Nov; 40(9):823-30. PubMed ID: 17724442
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].
Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386
[TBL] [Abstract][Full Text] [Related]
11. Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.
Confer DL; Abress LK; Navarro W; Madrigal A
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S8-S11. PubMed ID: 19892026
[TBL] [Abstract][Full Text] [Related]
12. Strategies for new donor typing based on donor HLA type or donor characteristics.
Little AM; Jindra P; Raffoux C
Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153
[TBL] [Abstract][Full Text] [Related]
13. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
[TBL] [Abstract][Full Text] [Related]
14. HLA-haploidentical donor transplantation in severe combined immunodeficiency.
Friedrich W; Hönig M
Immunol Allergy Clin North Am; 2010 Feb; 30(1):31-44. PubMed ID: 20113885
[TBL] [Abstract][Full Text] [Related]
15. Differential immunogenicity of HLA mismatches in clinical transplantation.
Claas FH; Dankers MK; Oudshoorn M; van Rood JJ; Mulder A; Roelen DL; Duquesnoy RJ; Doxiadis II
Transpl Immunol; 2005 Aug; 14(3-4):187-91. PubMed ID: 15982562
[TBL] [Abstract][Full Text] [Related]
16. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
17. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
[TBL] [Abstract][Full Text] [Related]
18. How to select the best available related or unrelated donor of hematopoietic stem cells?
Tiercy JM
Haematologica; 2016 Jun; 101(6):680-7. PubMed ID: 27252513
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
Aversa F; Reisner Y; Martelli MF
Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
[TBL] [Abstract][Full Text] [Related]
20. Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation.
Schellekens J; Rozemuller EH; Petersen EJ; van den Tweel JG; Verdonck LF; Tilanus MG
Mol Immunol; 2008 Feb; 45(4):981-9. PubMed ID: 17881057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
